Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 307

J&J Manages to Beat Earnings Despite Currency Drag

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) has now reported its first-quarter results, showing an 8.5% gain in sales to $17.5 billion, and earnings of $4.1 billion on a normalized earnings basis that came to…

Jon C. Ogg · 14 years ago

Gene Patent Showdown for Myriad Comes to a Head

ThinkstockShould a company get to patent your genetic DNA? That is the question when it comes to Myriad Genetics Inc. (NASDAQ: MYGN). This company and its stock are at the center of a multi-year…

Jon C. Ogg · 14 years ago

Thermo Fisher to Acquire Life Technologies

ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share). Thermo Fisher…

Paul Ausick · 14 years ago

America’s Fattest Cities

ThinkstockObesity may be the most closely followed health care issue in the United States. The rate of obesity has increased dramatically in the past two decades, growing from 13% in 1960 to 34% nationally.…

Mike Sauter · 14 years ago

America’s Most Obese Cities

ThinkstockAmerica’s least obese cities are Boulder; Charlottesville, Va.; Bellingham Wash.; Fort Collins, Colo.; Naples, Fla.; Denver; San Francisco; San Lois Obisco; Madison, Wisc.; and Colorado Springs. Many of these cities have relatively high income…

Douglas A. McIntyre · 14 years ago

More Worries About Boston Scientific Turnaround Story

Thinkstock24/7 Wall St. recently featured the waves of the most promising turnarounds for 2013. It was amazing to see some of the battered yet recovered stocks on that list. Some of the turnarounds we…

Jon C. Ogg · 14 years ago

How the U.S. Is Making the Rest of the World Fat

ThinkstockPeople who live in nations where most residents were thin, at least as measured against the tremendous number of obese Americans, are getting fatter. Bloomberg blames this, in part, on the number of fast…

Douglas A. McIntyre · 14 years ago

Another Major MS Approval Keeps Driving Biogen Idec

ThinkstockShares of Biogen Idec Inc. (NASDAQ: BIIB) did not just do well on Wednesday. The stock hit an all-time high. News hit late in the day that the U.S. Food and Drug Administration has…

Jon C. Ogg · 14 years ago

Aastrom Implosion Could Have Been Even Worse

ThinkstockAastrom Biosciences Inc. (NASDAQ: ASTM) has just joined in on the long list of biotech implosions. Perhaps the only thing that is so surprising after the fact, with a 35% price drop now, is…

Jon C. Ogg · 14 years ago

Chelsea Therapeutics Rally — Speculation or Desperation?

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic hypotension in Parkinson’s patients, a shoe-in for approval, along with the note…

Jon C. Ogg · 14 years ago